Reach Neuro, Inc.
PrivateLast Round
Angel
May 28, 2025
Total Funding Raised
$750,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Reach Neuro, Inc. operates in Healthcare & Life Sciences and is based in Providence, Rhode Island. Its latest recorded funding round was an Angel round in May 2025.
Reach Neuro, Inc. is a medical device company that develops implantable neuromodulation systems designed to restore upper-limb motor function in patients with chronic stroke.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reach Neuro, Inc. Comparables
Compare Reach Neuro, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enspire DBS Therapy, Inc. | 85% | |
| Mobia Medical | 78% | |
| Vivani Medical | 77% |
For institutional investors. Book with your work email.
Reach Neuro, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | May 28, 2025 | ||||
| Seed | Jun 1, 2024 | ||||
| Grant | Apr 10, 2023 | ||||
| Accelerator | Jan 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Reach Neuro, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Richard King Mellon Foundation | Seed |
| IndieBio | Accelerator |
| Angel Investor Forum | Angel |
| SOSV | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 129% MoM, reaching 2.1K.
- May 17, 2026
Monthly visitors grew 50% MoM.
For institutional investors. Book with your work email.
Reach Neuro, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Reach Neuro, Inc.'s valuation, stock price, and market status.
Is Reach Neuro, Inc. a public or private company?
Reach Neuro, Inc. is a private company.
What is the current stock price of Reach Neuro, Inc.?
Reach Neuro, Inc. is a private company, so its shares have no public market price. Caplight tracks Reach Neuro, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Reach Neuro, Inc. worth (valuation)?
Valuation information for Reach Neuro, Inc. is not publicly available.
Can I buy Reach Neuro, Inc. stock?
Reach Neuro, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Reach Neuro, Inc.'s last funding round?
Reach Neuro, Inc.'s most recent funding round was Angel on May 28, 2025.
Who are the main investors in Reach Neuro, Inc.?
Key investors in Reach Neuro, Inc. include IndieBio.
Will Reach Neuro, Inc. IPO soon?
No public IPO plans have been announced for Reach Neuro, Inc..
How can I track Reach Neuro, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Reach Neuro, Inc.'s shares on secondary markets.